• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

SLI European Equity Growth Fund Inc

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund Provider Standard Life
Fund Summary The objective of the fund is to provide capital appreciation. It is intended that income will not be a prime consideration. The investment policy of the Fund is to invest mostly in equities and equity type investments of companies listed on the main European markets or which, in the opinion of the ACD, carry on a significant part of their operations in Europe (including the UK). Up to 10% of the Fund may be invested in smaller emerging European makrets, as included in the MSCI Emerging Markets Indez from time-to-time. "Equity type investments" will include convertible stocks, stock exchange listed warrants, Depositary Receipts and any other such investments which entitle the holder to subscribe for or convert into the equity of the company and/or where the share price performance is, in the opinion of the ACD, influenced significantly by the stock market performance of the company's ordinary shares.
SEDOL code BYQNB52
ISIN GB00BYQNB524
Fund code SLEGI
Managers Jonathan Fearon
Manager Tenure 5 years
Morningstar Category Europe ex-UK Large-Cap Equity
IMA Sector Europe Excluding UK
Fund Size £88 million
Fund Type OEIC
Management Style Active
Total Expense Ratio (TER) 1.38%
Cavendish ongoing charge 0.05%
FundsNetwork Service Fee 0.20%
Minimum Initial Investment £25
Minimum Top Up £25
Minimum Monthly Investment £25
Sell Price £0.6603
Buy Price £0.6603
Price Change +0.7938%
Price Date 16th August 2019
Yield 1.52%
Dividend Frequency Yearly
ISA Eligible Yes
SIPP Eligible Yes
Inception Date 4th September 2015
Fund Status OPEN
Jonathan graduated from Exeter University in 2001 with a BA Honours degree in History. He began his career at Gartmore Investment Management in 2001 before joining Ignis in July 2006. Jonathan is a member of the CFA Institute /UKSIP.

3-year Mean Monthly Return: 0.774%

Annual Returns 2018 2017 2016
Fund Performance +0.52% +2.20% +32.20%
Benchmark Performance
(Europe ex-UK Large-Cap Equity)
+1.88% +3.34% +31.97%
Time Period Cumulative Benchmark Performance
(Europe ex-UK Large-Cap Equity)
Fund Compared to Benchmark
1 day 0.79% -0.73% +1.52%
1 week -2.90% +1.84% -4.74%
1 month -3.63% +4.19% -7.82%
3 months 2.29% +7.26% -4.97%
6 months 6.67% +9.29% -2.62%
1 year -2.42% -0.95% -1.48%
3 years 17.74% +37.55% -19.81%
5 years Currently unavailable +42.63% Currently unavailable
10 years Currently unavailable +155.21% Currently unavailable
YTD 12.64% +13.83% -1.19%
Since inception 38.69% Currently unavailable Currently unavailable

Top 10 shares for this fund

Share Name Country Value
Nestle SA CHE 4.91%
Novo Nordisk A/S B DNK 3.30%
Roche Holding AG Dividend Right Cert. CHE 3.25%
Total SA FRA 3.16%
ASML Holding NV NLD 3.04%
Kering SA FRA 2.96%
Airbus SE NLD 2.77%
AXA SA FRA 2.38%
Siemens AG DEU 2.34%
Enel SpA ITA 2.25%
Dividend Date Per share amount Reinvestment Price
1st March 2019 0.0096 £0.6234
1st March 2018 0.0115 £0.6797
1st March 2017 0.0105 £0.6101